| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: KESIMPTA (ofatumumab) | |
| ***************************************************** | |
| #Post#: 3818-------------------------------------------------- | |
| (Abst.) IV ofatumumab treatment of MS and related disorders... | |
| By: agate Date: October 26, 2022, 1:20 am | |
| --------------------------------------------------------- | |
| From PubMed (October 25, 2022)--"Intravenous ofatumumab | |
| treatment of multiple sclerosis and related disorders: An | |
| observational study": | |
| https://pubmed.ncbi.nlm.nih.gov/36279600/ | |
| ***************************************************** |